An ongoing dialogue on HIV/AIDS, infectious diseases,
December 17th, 2015
A Certain Billionaire’s Arrest Prompts Universal Responses — and a Brilliantly Funny One, Too
Several words swiftly come to mind when hearing the news that Turing’s Martin Shkreli was arrested for security fraud. Karma. Just desserts. Kismet. Schadenfreude. Inevitable. But leave it to Andy Borowitz to get it just right: Ha, that’s perfect. Diana Olson from IDSA emailed me “Someone should make a movie …”, which is of course exactly right. What a script: […]
September 24th, 2015
Decision to Lower Price of Pyrimethamine a Good One, Especially Given the Weak Defense of the Price Hike
The big ID story the past couple of weeks is that the price of pyrimethamine — a drug that’s been available generically for decades — went from $13.50 to $750 for one pill after the exclusive rights to the drug were purchased by Turing Pharmaceuticals. Now, after a barrage of criticism — all the way from this […]
Paul E. Sax, MD
Contributing Editor
NEJM Journal Watch
Infectious Diseases
Biography | Disclosures | Summaries
Learn more about HIV and ID Observations.
NEJM Journal Watch — Recent Infectious Disease Articles- Rising Rates of Perinatal HIV: Maryland, 2022
- Do Children Need a Booster of Typhoid Conjugate Vaccine?
- Infection with Tecovirimat-Resistant Mpox Virus Is on the Rise in the U.S.
- Kidney Transplantation: Offering HOPE for Those with HIV
- Observations from ID and Beyond: Brave New Name — How PCP Became PJP and Why It Matters